{"schema":"hottub-news/prospects/v1","item":{"id":"n_464fuq3bngfut4kdmgla","title":"Препараты GLP-1 RA: FDA предупредило о возможном риске потери зрения","title_en":null,"url":"https://iz.ru/2199251/fda-predupredilo-o-riske-poteri-zreniia-iz-za-preparatov-dlia-pokhudeniia-izi","outlet":"Izvestia","published":"2026-11-10T12:00:00Z","sponsored":false,"page":"https://hottub.news/articles/n_464fuq3bngfut4kdmgla"},"prospects":[{"name":"Izvestia","kind":"organization","role":"outlet","website":"https://iz.ru/","entity":"wikidata:Q753932","source":"https://iz.ru/2199251/fda-predupredilo-o-riske-poteri-zreniia-iz-za-preparatov-dlia-pokhudeniia-izi","note":"Published: Препараты GLP-1 RA: FDA предупредило о возможном риске потери зрения (2026-11-10)","reason":"Published “Препараты GLP-1 RA: FDA предупредило о возможном риске потери зрения” on 2026-11-10","group":"Outlet","add_url":"https://crm.joinhottub.com/relationships/add#name=Izvestia&kind=organization&website=https%3A%2F%2Fiz.ru%2F&source=https%3A%2F%2Fiz.ru%2F2199251%2Ffda-predupredilo-o-riske-poteri-zreniia-iz-za-preparatov-dlia-pokhudeniia-izi&entity=wikidata%3AQ753932&note=Published%3A%20%D0%9F%D1%80%D0%B5%D0%BF%D0%B0%D1%80%D0%B0%D1%82%D1%8B%20GLP-1%20RA%3A%20FDA%20%D0%BF%D1%80%D0%B5%D0%B4%D1%83%D0%BF%D1%80%D0%B5%D0%B4%D0%B8%D0%BB%D0%BE%20%D0%BE%20%D0%B2%D0%BE%D0%B7%D0%BC%D0%BE%D0%B6%D0%BD%D0%BE%D0%BC%20%D1%80%D0%B8%D1%81%D0%BA%D0%B5%20%D0%BF%D0%BE%D1%82%D0%B5%D1%80%D0%B8%20%D0%B7%D1%80%D0%B5%D0%BD%D0%B8%D1%8F%20%282026-11-10%29","propose":{"name":"Izvestia","kind":"organization","reason":"Published “Препараты GLP-1 RA: FDA предупредило о возможном риске потери зрения” on 2026-11-10","requestId":"news:n_464fuq3bngfut4kdmgla:wikidata:Q753932:c8a9ac90","website":"https://iz.ru/","sourceUrl":"https://iz.ru/2199251/fda-predupredilo-o-riske-poteri-zreniia-iz-za-preparatov-dlia-pokhudeniia-izi","entity":"wikidata:Q753932"}}],"someone_else":{"source":"https://iz.ru/2199251/fda-predupredilo-o-riske-poteri-zreniia-iz-za-preparatov-dlia-pokhudeniia-izi","note":"In the news: Препараты GLP-1 RA: FDA предупредило о возможном риске потери зрения (Izvestia, 2026-11-10)"},"crm":{"name":"CRM by Hottub","add":"Open add_url in a browser: CRM by Hottub's add form, filled in. Nothing is saved until the person presses Add.","mcp":"https://crm.joinhottub.com/api/crm/mcp","tool":"propose_relationship","propose":"If you're connected to CRM by Hottub's MCP server with proposal access, call propose_relationship with `propose` as its arguments. An owner approves it before anything is added. Keep the arguments as given: retries reuse requestId."}}